Literature DB >> 3787427

Proximal gastric vagotomy in emergency peptic ulcer perforation.

S Choi, J Boey, T T Alagaratnam, A Poon, J Wong.   

Abstract

In order to evaluate proximal gastric vagotomy (PGV) performed under different clinical conditions, we compared the late results of 93 patients who underwent emergency PGV for perforated duodenal ulcers with those of 60 patients who had elective PGV. The emergency group of patients were slightly younger and there was a higher male predominance but they were otherwise comparable with those in the elective group. There were no operative deaths and the postoperative morbidity rate was low in both groups. Three patients had a recurrence in the emergency group, and seven occurred in those in the elective group during the first three postoperative years. The cumulative recurrence-free rate of the emergency group was not lower than that of the elective group. The performance of the individual surgeon exerted a strong influence on the incidence of recurrent ulceration. In properly selected patients, whether the surgeons perform PGV in emergency or elective situations appears to have little influence on the outcome.

Entities:  

Mesh:

Year:  1986        PMID: 3787427

Source DB:  PubMed          Journal:  Surg Gynecol Obstet        ISSN: 0039-6087


  4 in total

1.  Perforated duodenal ulcers.

Authors:  J Boey; J Wong
Journal:  World J Surg       Date:  1987-06       Impact factor: 3.352

2.  Indications for parietal cell vagotomy without drainage in gastrointestinal surgery.

Authors:  P H Jordan
Journal:  Ann Surg       Date:  1989-07       Impact factor: 12.969

3.  Changes in surgical strategies for peptic ulcers before and after the introduction of H2-receptor antagonists and endoscopic hemostasis.

Authors:  M Ishikawa; S Ogata; M Harada; Y Sakakihara
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

4.  Perforated pyloroduodenal ulcers. Long-term results with omental patch closure and parietal cell vagotomy.

Authors:  P H Jordan; J Thornby
Journal:  Ann Surg       Date:  1995-05       Impact factor: 12.969

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.